Skip to main content
Clinical Trials/IRCT2016071113456N6
IRCT2016071113456N6
Completed
Phase 2

Investigating the protective effect of dexmedetomidine on myocardial injury in on-pump coronary artery bypass grafting (CABG) surgery

Vice chancellor for research of Guilan University of Medical Sciences0 sites110 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
myocardial injury.
Sponsor
Vice chancellor for research of Guilan University of Medical Sciences
Enrollment
110
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research of Guilan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Isolated and elective CABG surgery; Age 35 to 65 years old;3 or 4 coronary artery stenosis; EF\>45%;Normal sinus rhythm and normal heart rate; myocardial enzymes troponin and CK\-MB levels before surgery in normal range; Exclusion criteria:Heart Rate\<50; SBP\<90 mmHg;Thyroid dysfunction
  • uncontrolled diabetes; History of corticosteroid therapy; addiction

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials